Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice

Journal of Hepatology

Volumn 45, Issue 3, 2006, Pages 419-428

  Czochra, Piotr ^a   Klopcic, Borut ^a   Meyer, Erik ^a   Herkel, Johannes ^a   Garcia Lazaro, Jose Francisco ^a   Thieringer, Florian ^a   Schirmacher, Peter ^b   Biesterfeld, Stefan ^a   Galle, Peter R ^a   Lohse, Ansgar W ^c   Kanzler, Stephan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Albumin promoter; Carbon tetrachloride; Hepatic stellate cells; Liver fibrosis; PDGF B; TGF ; Transgenic mice

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CRE RECOMBINASE; GELATINASE A; GELATINASE B; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; PREALBUMIN; TAMOXIFEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREEDING; CELL ACTIVATION; GENE OVEREXPRESSION; HISTOLOGY; LIVER FIBROSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HEPATOCYTES; INTEGRASES; LIVER; LIVER CIRRHOSIS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-SIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746561298     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.04.010     Document Type: Article

References (54)

1. Ahn J., and Flamm S.L. Hepatocellular carcinoma. Dis Mon 50 (2004) 556-573
2. Friedman S.L. Liver fibrosis - from bench to bedside. J Hepatol 38 Suppl 1 (2003) S38-S53
3. Bissell D.M., Roulot D., and George J. Transforming growth factor beta and the liver. Hepatology 34 (2001) 859-867
4. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., Roberts A.B., Sporn M.B., and Thorgeirsson S.S. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92 (1995) 2572-2576
5. Clouthier D.E., Comerford S.A., and Hammer R.E. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest 100 (1997) 2697-2713
6. Kanzler S., Lohse A.W., Keil A., Henninger J., Dienes H.P., Schirmacher P., Rose-John S., zum Büschenfelde K.H., and Blessing M. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276 (1999) G1059-G1068
7. Ueberham E., Low R., Ueberham U., Schonig K., Bujard H., and Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37 (2003) 1067-1078
8. Heldin C.H., Eriksson U., and Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 398 (2002) 284-290
9. Pinzani M., Carloni V., Marra F., Riccardi D., Laffi G., and Gentilini P. Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. Gastroenterology 106 (1994) 1301-1311
10. Pinzani M., Milani S., Herbst H., DeFranco R., Grappone C., Gentilini A., Caligiuri A., Pellegrini G., Ngo D.V., Romanelli R.G., and Gentilini P. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 148 (1996) 785-800
11. Hoyle G.W., Li J., Finkelstein J.B., Eisenberg T., Liu J.Y., Lasky J.A., Athas G., Morris G.F., and Brody A.R. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol 154 (1999) 1763-1775
12. Hui A.Y., and Friedman S.L. Molecular basis of hepatic fibrosis. Exp Rev Mol Med [electronic resource] 2003 (2003) 1-23
13. Pinzani M., Gesualdo L., Sabbah G.M., and Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84 (1989) 1786-1793
14. Pinzani M. Platelet-derived growth factor receptor expression in hepatic stellate cells: how too much of a good thing can be bad. Hepatology (Baltimore, MD) 22 (1995) 997-999
15. Schwenk F., Baron U., and Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23 (1995) 5080-5081
16. Tannour-Louet M., Porteu A., Vaulont S., Kahn A., and Vasseur-Cognet M. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology (Baltimore, MD) 35 (2002) 1072-1081
17. Fleenor D.E., and Kaufman R.E. Characterization of the DNase I hypersensitive site 3′ of the human beta globin gene domain. Blood 81 (1993) 2781-2790
18. Li Q., and Stamatoyannopoulos G. Hypersensitive site 5 of the human beta locus control region functions as a chromatin insulator. Blood 84 (1994) 1399-1401
19. Blessing M., Nanney L.B., King L.E., Jones C.M., and Hogan B.L. Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev 7 (1993) 204-215
20. Gorski K., Carneiro M., and Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47 (1986) 767-776
21. Schèonrich G., Momburg F., Malissen M., Schmitt-Verhulst A.M., Malissen B., Hèammerling G.J., and Arnold B. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 4 (1992) 581-590
22. Werner S., Weinberg W., Liao X., Peters K.G., Blessing M., Yuspa S.H., Weiner R.L., and Williams L.T. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J 12 (1993) 2635-2643
23. Sternberg N., and Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150 (1981) 467-486
24. Sauer B., and Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85 (1988) 5166-5170
25. Reponen P., Sahlberg C., Huhtala P., Hurskainen T., Thesleff I., and Tryggvason K. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J Biol Chem 267 (1992) 7856-7862
26. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196 (1987) 947-950
27. Hogan B.L.M., Costatini F., and Lacy E. Manipulating the mouse embryo. A laboratory manual (1986), Cold Spring Harbor Laboratory Press
28. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15 (1993) 532-534 536-537
29. Church G.M., and Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 81 (1984) 1991-1995
30. Todor D.R., Lewis I., Bruno G., and Chyatte D. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 29 (1998) 1580-1583
31. Reddy G.K., and Enwemeka C.S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29 (1996) 225-229
32. Knittel T., Mehde M., Grundmann A., Saile B., Scharf J.G., and Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 113 (2000) 443-453
33. Kossakowska A.E., Edwards D.R., Lee S.S., Urbanski L.S., Stabbler A.L., Zhang C.L., Phillips B.W., Zhang Y., and Urbanski S.J. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 153 (1998) 1895-1902
34. Yoshiji H., Kuriyama S., Miyamoto Y., Thorgeirsson U.P., Gomez D.E., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., Tsujinoue H., Nakatani T., Thorgeirsson S.S., and Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32 (2000) 1248-1254
35. Canbay A., Higuchi H., Bronk S.F., Taniai M., Sebo T.J., and Gores G.J. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123 (2002) 1323-1330
36. Kinnman N., Francoz C., Barbu V., Wendum D., Rey C., Hultcrantz R., Poupon R., and Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83 (2003) 163-173
37. Carloni V., Romanelli R.G., Pinzani M., Laffi G., and Gentilini P. Focal adhesion kinase and phyospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112 (1997) 522-531
38. Carloni V., Romanelli R.G., Pinzani M., Laffi G., and Gentilini P. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 110 (1996) 1127-1136
39. Iwamoto H., Nakamuta M., Tada S., Sugimoto R., Enjoji M., and Nawata H. Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth. J Lab Clin Med 135 (2000) 406-412
40. Yoshiji H., Noguchi R., Kuriyama S., Ikenaka Y., Yoshii J., Yanase K., et al. Imatinib mesylate (STI571: Gleevec) attenuates liver fibrosis development in rats. Am J Physiol Gastrointest Liver Physiol (2004)
41. Borkham-Kamphorst E., Herrmann J., Stoll D., Treptau J., Gressner A.M., and Weiskirchen R. Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest 84 (2004) 766-777
42. Ramadori G., and Saile B. Mesenchymal cells in the liver - one cell type or two?. Liver 22 (2002) 283-294
43. Kobold D., Grundmann A., Piscaglia F., Eisenbach C., Neubauer K., Steffgen J., Ramadori G., and Knittel T. Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. J Hepatol 36 (2002) 607-613
44. Ojima Y., Mizuno M., Kuboki Y., and Komori T. In vitro effect of platelet-derived growth factor-BB on collagen synthesis and proliferation of human periodontal ligament cells. Oral Dis 9 (2003) 144-151
45. Lepisto J., Peltonen J., Vaha-Kreula M., Soderstrom K., Niinikoski J., and Laato M. Selective modulation of collagen gene expression by different isoforms of platelet-derived growth factor in experimental wound healing. Cell Tissue Res 286 (1996) 449-455
46. Borkham-Kamphorst E., Stoll D., Gressner A.M., and Weiskirchen R. Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells. Biochem Biophys Res Commun 317 (2004) 451-462
47. Czuwara-Ladykowska J., Gore E.A., Shegogue D.A., Smith E.A., and Trojanowska M. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts. Br J Dermatol 145 (2001) 569-575
48. Taylor L.M., and Khachigian L.M. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J Biol Chem 275 (2000) 16709-16716
49. Milani S., Herbst H., Schuppan D., Grappone C., Pellegrini G., Pinzani M., et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 144 (1994) 528-537
50. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102 (1998) 538-549
51. Arthur M.J., Stanley A., Iredale J.P., Rafferty J.A., Hembry R.M., and Friedman S.L. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 287 Pt 3 (1992) 701-707
52. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
53. Borkham-Kamphorst E., Stoll D., Gressner A.M., and Weiskirchen R. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. Biochem Biophys Res Commun 321 (2004) 413-423
54. Kamada Y., Tamura S., Kiso S., Matsumoto H., Saji Y., Yoshida Y., et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125 (2003) 1796-1807